StonvexLoading…
StonvexStonvexStonvexCore line items from EG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $17.50B | $17.28B | $14.59B | $12.06B |
Operating Income | $1.89B | $1.49B | $2.15B | $588.00M |
Net Income | $1.59B | $1.37B | $2.52B | $597.00M |
EPS (Diluted) | $37.80 | $31.78 | $60.19 | $15.19 |
Total Assets | $62.51B | $56.34B | $49.40B | $39.97B |
Total Liabilities | $47.05B | $42.47B | $36.20B | $31.52B |
Cash & Equivalents | $1.32B | $1.55B | $1.44B | $1.40B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 74.40M | 74.30M | 74.20M | 69.90M |